Enviar artigo por via de e-mail Effects of Bariatric Surgeries on the Size of Myocardial Infarction and Ghrelin Level in Rats with Experimental Decompensated Type 2 Diabetes Mellitus
- Autores: Kornyushin O.V.1, Sonin D.L.1, Toropova Y.G.1, Pochkaeva E.I.1, Semikova G.V.2, Berko O.M.2, Zelinskaya I.A.1, Todosenko N.M.3, Litvinova L.S.3, Neimark A.E.4, Babenko A.Y.4, Dergach K.V.5, Schpakov A.O.5, Galagudza M.M.1,2
-
Afiliações:
- Institute of Experimental Medicine
- I. P. Pavlov First St. Petersburg State Medical University, Ministry of Health of the Russian Federation
- Laboratory of Immunology and Cell Biotechnology, Immanuel Kant Baltic Federal University
- Institute of Endocrinology, V. A. Almazov National Medical Research Center, Ministry of Health of the Russian Federation
- Laboratory of Molecular Endocrinology and Neurochemistry, I. M. Sechenov Institute of Evolutional Physiology and Biochemistry, Russian Academy of Sciences
- Edição: Volume 168, Nº 2 (2019)
- Páginas: 210-213
- Seção: Article
- URL: https://journal-vniispk.ru/0007-4888/article/view/242365
- DOI: https://doi.org/10.1007/s10517-019-04676-w
- ID: 242365
Citar
Acesso aberto
Acesso está concedido
Somente assinantes
Resumo
The effects of bariatric surgeries (sleeve gastrectomy and ileal transposition) on the dynamics of changes in ghrelin level were studied in rats with severe decompensated type 2 diabetes mellitus under conditions of glucose challenge as well as on the size of myocardial infarction in these animals. Diabetes was modelled by high fat diet and a single administration of streptozotocin (25 mg/kg, intraperitoneally). Both bariatric surgeries significantly decreased glucose-induced ghrelin level in the blood of rats with type 2 diabetes mellitus, which attested to an increase in the tissue sensitivity to ghrelin. Sleeve gastrectomy resulted in a decrease in the size of myocardial infarction in diabetic rats, which was calculated as the ratio of the necrosis zone to the zone of the risk of myocardial infarction. Ileal transposition had no effect on this parameter. Our data can be used as the basis for optimization of treatment approaches when using bariatric surgery in the treatment of patients with severe forms of type 2 diabetes mellitus with a high risk of cardiovascular diseases.
Sobre autores
O. Kornyushin
Institute of Experimental Medicine
Autor responsável pela correspondência
Email: o.kornyushin@gmail.com
Rússia, St. Petersburg
D. Sonin
Institute of Experimental Medicine
Email: o.kornyushin@gmail.com
Rússia, St. Petersburg
Ya. Toropova
Institute of Experimental Medicine
Email: o.kornyushin@gmail.com
Rússia, St. Petersburg
E. Pochkaeva
Institute of Experimental Medicine
Email: o.kornyushin@gmail.com
Rússia, St. Petersburg
G. Semikova
I. P. Pavlov First St. Petersburg State Medical University, Ministry of Health of the Russian Federation
Email: o.kornyushin@gmail.com
Rússia, St. Petersburg
O. Berko
I. P. Pavlov First St. Petersburg State Medical University, Ministry of Health of the Russian Federation
Email: o.kornyushin@gmail.com
Rússia, St. Petersburg
I. Zelinskaya
Institute of Experimental Medicine
Email: o.kornyushin@gmail.com
Rússia, St. Petersburg
N. Todosenko
Laboratory of Immunology and Cell Biotechnology, Immanuel Kant Baltic Federal University
Email: o.kornyushin@gmail.com
Rússia, Kaliningrad
L. Litvinova
Laboratory of Immunology and Cell Biotechnology, Immanuel Kant Baltic Federal University
Email: o.kornyushin@gmail.com
Rússia, Kaliningrad
A. Neimark
Institute of Endocrinology, V. A. Almazov National Medical Research Center, Ministry of Health of the Russian Federation
Email: o.kornyushin@gmail.com
Rússia, St. Petersburg
A. Babenko
Institute of Endocrinology, V. A. Almazov National Medical Research Center, Ministry of Health of the Russian Federation
Email: o.kornyushin@gmail.com
Rússia, St. Petersburg
K. Dergach
Laboratory of Molecular Endocrinology and Neurochemistry, I. M. Sechenov Institute of Evolutional Physiology and Biochemistry, Russian Academy of Sciences
Email: o.kornyushin@gmail.com
Rússia, St. Petersburg
A. Schpakov
Laboratory of Molecular Endocrinology and Neurochemistry, I. M. Sechenov Institute of Evolutional Physiology and Biochemistry, Russian Academy of Sciences
Email: o.kornyushin@gmail.com
Rússia, St. Petersburg
M. Galagudza
Institute of Experimental Medicine; I. P. Pavlov First St. Petersburg State Medical University, Ministry of Health of the Russian Federation
Email: o.kornyushin@gmail.com
Rússia, St. Petersburg; St. Petersburg
Arquivos suplementares
